Industry reports
Editor highlights

Publication dates

Influenza Vaccine Research Reports, April 2014

You might be interested in: vaccine, drug, influenza, more »


 

1-10 of about 100 reports for Influenza Vaccine
Panacea Biotec Limited - Product Pipeline Review - 2014

Panacea Biotec Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • March 2014
  • by Global Markets Direct

... Respiratory syncytial virus vaccine 42product description 42mechanism of action 42r&d progress 42universal recombinant influenza vaccine 43product description 43mechanism of action 43 ...

BioDiem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioDiem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Summary, 2008 to ytd 2014 8biodiem ltd, pharmaceuticals & healthcare, deal details 9partnerships 9biodiem enters into research agreement with rmit university for non-influenza vaccines 9 ...

Emergent BioSolutions Inc. (EBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emergent BioSolutions Inc. (EBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... With vaxinnate for pandemic influenza vaccine 33emergent biosolutions amends licensing agreement with pfizer 34oxford biomedica enters into licensing agreement with emergent product development ...

Hualan Biological Engineering, Inc. (002007) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hualan Biological Engineering, Inc. (002007) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... And surgical lyophilized fibrin sealant. Hualan biological offers vaccines such as inactivated influenza vaccine, recombinant hepatitis b vaccine, meningococcal polysaccharide vaccine group acyw135 and influenza ...

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Sinovac Biotech Ltd. (SVA)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Sinovac Biotech Ltd. (SVA)

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Pandemic influenza vaccine; and rabend, a animal rabies vaccine. The company has completed a phase i clinical trial of a sars vaccine. Sinovac biotech also develops the ev71 vaccine, which has completed ...

Vaxart, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vaxart, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Delivery vaccines to prevent viral-based infectious diseases. Its products include avian influenza h5n1 oral vaccine, annual influenza vaccine and pandemic h1n1 swine flu vaccine. Vaxart has developed a double ...

VaxInnate Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VaxInnate Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... And manufactures novel vaccines for pandemic and seasonal influenza. Its product pipeline includes flagellin.Huha and flagellin.Avha. Vaxinnate provides influenza vaccines. The company partners with an academic ...

Vivaldi Biosciences Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vivaldi Biosciences Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Attenuated influenza vaccines (laivs) for the prevention of seasonal and pandemic influenza. Vivaldi's laivs induce potent and protective antibody and cellular immune responses. Its intellectual property ...

Xenetic Biosciences plc (XEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xenetic Biosciences plc (XEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... Imuxen for vaccine delivery and oncohist. Its polyxen products include erepoxen, sulixen, pulmoxen and psa-rfviii cand. Xenetic also provides imuxen products such as myeloxen, influenza vaccine ...

Medicago Inc. (MDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medicago Inc. (MDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

... vaccines. Medicago is headquartered in sainte-foy, quebec, canada.Medicago inc. (Mdg) - pharmaceuticals & healthcare - deals and alliances profile provides you comprehensive data and trend analysis ...


» Read our Company Profiles

2 Companies for Influenza Vaccine

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.